Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis

Molecular Brain Research

Volumn 72, Issue 1, 1999, Pages 17-29

  Kopp, Jutta ^a   Nanobashvili, Avtandil ^b   Kokaia, Zaal ^b   Lindvall, Olle ^b   Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Epilepsy; Gene expression; Kindling; Neuropeptide Y; Neuropeptide Y receptor

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; RECEPTOR SUBTYPE;

ADOLESCENT; AMYGDALOID NUCLEUS; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DENTATE GYRUS; ENTORHINAL CORTEX; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION REGULATION; GRANULE CELL; KINDLING; LIMBIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; PYRIFORM CORTEX; RAT; SOMATOSENSORY CORTEX;

EID: 0032826086     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00191-6     Document Type: Article

References (63)

1. Balasubramaniam A., Sheriff S., Rigel D.F., Fischer J.E. Characterization of neuropeptide Y binding in rat cardiac ventricular membranes. Peptides. 11:1990;545-550.
2. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17:1997;8927-8936.
3. Bard J.A., Walker M.W., Branchek T.A., Weinschank R.L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270:1995;26762-26765.
4. Bendotti C., Vezzani A., Tarizzo G., Samanin R. Increased expression of GAP-43, somatostatin and neuropeptide Y mRNA in the hippocampus during development of hippocampal kindling in rats. Eur. J. Neurosci. 5:1993;1312-1320.
5. Bengzon J., Kokaia Z., Elmér E., Nanobashivili A., Kokaia M., Lindvall O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10432-10437.
6. P.A. Brooks, J.S. Kelly, J.M. Allen, S.A.S. Smith, T.W. Stone, Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurons in vitro, Brain Res., 1987, pp. 295-298.
7. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 15:1985;1159-1181.
8. Colmers W.F., Klapstein G.J., Fournier A., St-Pierre S., Treherne K.A. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br. J. Pharmacol. 102:1991;41-44.
9. Dagerlind Å., Friberg K., Bean A.J., Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry. 98:1992;39-49.
10. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system: II. Immunohistochemical analysis. Neuroscience. 18:1986;545-618.
11. Dumont Y., Fournier A., Quirion R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci. 18:1998;5565-5574.
12. Dumont Y., St Pierre J.A., Quirion R. Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport. 7:1996;901-904.
13. Elmer E., Kokaia M., Kokaia Z., Ferencz I., Lindvall O. Delayed kindling development after rapidly recurring seizures: relation to mossy fiber sprouting and neurotrophin, GAP-43 and dynorphin gene expression. Brain Res. 712:1996;19-34.
14. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-418.
15. Eva C., Keinänen K., Monyer H., Seeburg P., Sprengel R. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Letters. 271:1990;81-84.
16. Gariboldi M., Conti M., Cavaleri D., Samanin R., Vezzani A. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Eur. J. Neurosci. 10:1998;757-759.
17. Gehlert D.R., Beavers L.S., Johnson D., Gackenheimer S.L., Schober D.A., Gadski R.A. Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol. Pharmacol. 49:1996;224-228.
18. Gehlert D.R., Chronwall B.M., Schafer M.P., O'Donohue T.L. Localization of neuropeptide Y messenger ribonucleic acid in rat and mouse brain by in situ hybridization. Synapse. 1:1987;25-31.
19. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzi-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linnemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.L., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
20. Gerald D., Walker M.W., Vaysse P.J.J., He W., Branchek T.A., Weinshank R.L. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. Biol. Chem. 270:1995;25758-25761.
21. Glaum S.R., Miller R.J., Rhim H., MacLean D., Georgic L.M., MacKenzie R.G., Grundemar L. Characterization of Y3 receptor mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem. Br. J. Pharmacol. 120:1997;481-487.
22. Gobbi M., Gariboldi M., Piwko C., Hoyer D., Sperk G., Vezzani A. Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J. Neurochem. 70:1998;1615-1622.
23. Gobbi M., Monhemius R., Samanin R., Mennini T., Vezzani A. Cellular localization of neuropeptide-Y receptors in the rat hippocampus: long-term effects of limbic seizures. Neuroreport. 7:1996;1475-1480.
24. Goddard G.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25:1969;295-330.
25. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113:1994;737-740.
26. Gregor P., Feng Y., DeCarr L.B., Cornfield L.J., McCaleb M.L. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homolog. J. Biol. Chem. 271:1996;27776-27781.
27. Grundemar L., Håkanson R. Neuropeptide Y effector systems: perspectives for drug development. Trends Parmacol. Sci. 15:1994;153-159.
28. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., Branchek T.A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol. Brain Res. 46:1997;223-235.
29. Hu Y., Bloomquist B.T., Cornfield L.J., DeCarr L.B., Flores-Riveros J.R., Friedman L., Jiang P., Lewis-Higgins L., Sadlowski Y., Schaefer J., Velazquez N., McCaleb M.L. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. 271:1996;26315-26319.
30. Jacques D., Tong Y., Shen S.H., Quirion R. Discrete distribution of the neuropeptide Y Y-5 receptor gene in the human brain: an in situ hybridization study. Mol. Brain Res. 61:1998;100-107.
31. Klapstein G.J., Colmers W.F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vivo. Hippocampus. 3:1993;103-112.
32. Kofler N., Kirchmair E., Schwarzer C., Sperk G. Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats. Neurosci. Lett. 230:1997;129-132.
33. Köhler C., Eriksson L., Davies S., Chan-Palay V. Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J. Comp. Neurol. 244:1986;384-400.
34. Kokaia M., Bengzon J., Kalén P., Lindvall O. Noradrenergic mechanisms in hippocampal kindling with rapidly recurring seizures. Brain Res. 491:1989;398-402.
35. Larhammar D., Ericsson A., Persson H. Structure and expression of rat neuropeptide Y gene. Proc. Natl. Acad. Sci. U.S.A. 84:1987;2068-2072.
36. Larsen P.J., Sheikh S.P., Jacobsen C.R., Schwartz T.W., Mikkelsen J.D. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur. J. Neurosci. 5:1993;1622-1637.
37. Larsen P.J., Sheikh S.P., Mikkelsen J.D. Neuropeptide Y Y1 receptors in the rat forebrain: autoradiographic demonstration of [125I][Leu31,Pro34]-NPY binding sites and neurons expressing Y1 receptor mRNA. J. Recept. Signal Transduction Res. 15:1995;457-472.
38. Lundell I., Blomqvist A.G., Berglund M.M., Schobers D.A., Johnson D., Statnick M.A., Gadski R.A., Gehlert D.R., Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. 270:1995;29123-29128.
39. Matsumoto M., Nomura T., Momose K., Ikeda Y., Kondou Y., Akiho H., Togami J., Kimura Y., Okada M., Yamaguchi T. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. 271:1996;27217-27220.
40. McQuiston A.R., Petrozzino J.J., Connor J.A., Colmers W.F. Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci. 16:1996;1422-1429.
41. Monnet F.P., Fournier A., Debonnel G., De Montigny C. Neuropeptide Y pontentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. Involvement of an atypical neuropeptide Y receptor. J. Pharmacol. Exp. Ther. 263:1992;1212-1218.
42. Morris B.J. Neuronal localisation of neuropeptide Y gene expression in rat brain. J. Comp. Neurol. 290:1989;358-368.
43. Nakamura M., Aoki Y., Hirano D. Cloning and functional expression of a cDNA encoding a mouse type 2 neuropeptide Y receptor. Biochim. Biophys. Acta. 1284:1996;134-137.
44. Nakamura M., Tokoyama M., Watanabe H., Matsumoto T. Molecular cloning, organization and localization of the gene for the mouse neuropeptide Y-Y5 receptor. Biochim. Biophys. Acta. 2:1997;83-89.
45. Naveilhan P., Neveu I., Arenas E., Ernfors P. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience. 87:1998;289-302.
46. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
47. Rimland J.M., Seward E.P., Humbert Y., Ratti E., Trist D.G., North R.A. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y. Mol. Pharmacol. 49:1996;387-390.
48. Rizzi M., Monno A., Samanin R., Sperk G., Vezzani A. Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur. J. Neurosci. 5:1993;1534-1538.
49. Röder C., Schwarzer C., Vezzani A., Gobbi M., Mennini T. Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience. 70:1996;47-55.
50. Rose M.R., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 270:1995;22661-22664.
51. Schalling M., Seroogy K., Hökfelt T., Chai S.Y., Persson H., Larhammar D., Ericsson A., Terenius L., Graffi J., Massoulié J., Goldstein M. Neuropeptide tyrosine in the rat adrenal gland - immunohistochemical and in situ hybridization studies. Neuroscience. 24:1988;337-349.
52. Schwarzer C., Kofler N., Sperk G. Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol. Pharmacol. 53:1998;6-13.
53. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A. Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev. 22:1996;27-50.
54. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 69:1995;831-845.
55. Sperk G., Marksteiner J., Gruber B., Bellmann R., Mahata M., Ortler M. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience. 50:1992;831-846.
56. St-Pierre J., Dumont Y., Dominique N., Herzog H., Hamel E., Quirion R. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurones and cloning of the rat Y2 receptor. Br. J. Pharmacol. 123:1998;183-194.
57. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22:1999;25-30.
58. Wahlestedt C., Ekman R., Widerlov E. Neuropeptide Y (NPY) and the central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 13:1989;31-54.
59. Wahlestedt C., Regunathan S., Reis D.J. Identification of cultured cells selectively expressing Y1-, Y2- or Y3-type receptors for neuropeptide Y/peptide YY. Life Science. 50:1992;7-12.
60. Widdowson P.S., Buckingham R., Williams G. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors. Brain Res. 778:1997;242-250.
61. Woldbye D.P.D., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat. Med. 3:1997;761-764.
62. W.S.I. Young, In situ hybridization histochemistry, in: A. Björklund, T. Hökfelt, F.G. Wouterlood, A.N. Van den Pol (Eds.), Handbook of Chemical Neuroanatomy, Vol. 8, Analysis of Neuronal Microcircuits and Synaptic Interactions, Amsterdam, 1990, pp. 481-512.
63. Zukowska-Grojec Z., Neuropeptide Y. A novel sympathetic stress hormone and more. Ann. N. Y. Acad. Sci. 771:1995;219-233.